The Business
Research Company’s latest report Inhalation Sedatives Global Market Report 2020
covers Inhalation Sedatives market drivers, Inhalation Sedatives market trends,
Inhalation Sedatives market segments,
Inhalation Sedatives market growth rate, Inhalation Sedatives market major
players, and Inhalation Sedatives market size. The report provides in-depth
analysis of the impact of COVID-19 on the Inhalation Sedatives industry, along
with revised market numbers due to the effects of the coronavirus.
View Complete Report:
Request for the sample now:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3468&type=smp
The global inhalation sedatives market is
expected to increase from $1.27 billion in 2019 to $1.29 billion in 2020 at a
compound annual growth rate (CAGR) of 1.2%. The growth is mainly due to the
COVID-19 outbreak. The infected individuals with severe ARDS require sedation
most frequently, and inhalation sedatives are being increasingly considered as
they are associated with rapid onset of inhalation and effective outcomes.
Inhaled sedatives can reduce lung inflammation, shorten the duration of
ventilation and potentially improve survival. The market is then expected to
stabilize and reach $1.48 billion in 2023 at a CAGR of 4.8%.
The report covers
the Inhalation Sedatives market’s segments-
1) By Product:
Sevoflurane, Desflurane, Isoflurane, Nitrous Oxide.
2) By
Application: Induction, Maintenance.
3) By End-User:
Hospitals, Ambulatory Surgical Centers, Others.
About
The Business Research Company:
The Business Research Company is a Business Intelligence Company which
excels in company, market and consumer research. It has offices in the UK, the
US and India and a network of trained researchers in 15 countries
globally.
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
No comments:
Post a Comment